Ignite Creation Date:
2024-05-06 @ 4:04 PM
Last Modification Date:
2024-10-26 @ 2:02 PM
Study NCT ID:
NCT04855045
Status:
UNKNOWN
Last Update Posted:
2022-03-25
First Post:
2021-04-13
Brief Title:
An Open-label Dose Escalation and Double-masked Randomized Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children 8 Years of Age With LCA10 Caused by Mutations in the CEP290 Gene
Sponsor:
ProQR Therapeutics
Organization:
ProQR Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-13
First Submit QC Date:
April 21 2021
Study First Post Date:
2021-04-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-03-25
Last Update Post Date Type:
ACTUAL